VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XRAY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XRAYDENTSPLY SIRONA Inc.
$10.82$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksXRAYBalance Sheet

DENTSPLY SIRONA Inc. (XRAY) Balance Sheet

30Y historyFree accessUpdated daily

The company's financial foundation appears increasingly vulnerable, with the debt-to-equity ratio surging to 1.77 in 2026Q1 compared to 0.70 in 2023Q4.

XRAY Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets1.84B2.02B1.75B1.97B1.89B1.85B1.8B2B1.89B2B1.88B1.2B1.21B1.14B1.11B1.01B1.32B1.22B949.86M982.02M718.19M1.03B1.06B727.45M541M484.24M325.45M314.7M322.5M277M256.7M
Cash & Short-Term Investments190M326M272M334M365M339M438M405M309.6M320.6M383.9M284.6M151.64M74.95M80.13M77.13M540.04M450.38M204.25M316.32M65.14M434.52M506.37M163.75M25.65M33.71M15.43M7.3M8.7M9.8M5.6M
Cash Only190M326M272M334M365M339M438M405M309.6M320.6M383.9M284.6M151.64M74.95M80.13M77.13M540.04M450.35M203.99M169.38M65.06M434.52M506.37M163.75M25.65M33.71M15.43M7.3M8.7M9.8M5.6M
Short-Term Investments0000000000000000037K258K146.94M79K0000000000
Accounts Receivable622M688M606M756M685M803M706M828M701.9M746.2M636M399.9M426.6M472.8M442.41M427.71M344.8M348.68M319.26M307.62M290.79M254.82M238.87M241.38M221.26M191.53M133.64M127.91M134.2M114.4M102M
Days Sales Outstanding64.768.2458.3269.5963.7569.2777.1875.1464.2768.261.9854.5853.2858.4855.1461.5256.6658.9253.1255.8758.6254.2351.4656.0953.3561.9254.8256.1961.6157.9356.7
Inventory659M642M564M624M627M515M476M562M598.9M623.1M517.1M340.4M387.1M438.56M402.94M361.76M308.74M291.64M306.13M258.03M232.44M208.18M213.71M205.59M214.49M197.45M133.3M135.5M139.2M124.7M125.4M
Days Inventory Outstanding129.21127.35112.19121.21127.599.77103.23110.4113.94126.01108.2107.38106.81116.56107.19104.44103.3101.51107.2597.1996.2589.892.0294.07100.26128.83126.43137.65148.91142.41150.66
Other Current Assets374M367M153M146M88M84M67M84M172.8M120.7M122.9M132.9M150.08M121.36M130.73M113.41M0-37K000-3.04M028.26M061.55M43.07M44M40.4M28.1M23.7M
Total Non-Current Assets3.38B3.41B4.01B5.4B5.75B7.39B7.55B6.6B6.8B8.38B9.77B3.21B3.44B3.93B3.86B3.74B1.94B1.87B1.88B1.69B1.46B1.38B1.74B1.72B1.55B1.31B541.16M544.9M572.8M497.4M411M
Property, Plant & Equipment997M1B902M978M961M971M967M961M870.6M876M799.8M558.8M588.85M637.17M614.71M591.45M423.11M439.62M432.28M371.41M329.62M316.22M407.53M376.21M313.18M240.89M181.34M180.5M159M147.1M141.5M
Fixed Asset Turnover3.73x3.68x4.21x4.05x4.08x4.36x3.45x4.19x4.58x4.56x4.68x4.79x4.96x4.63x4.76x4.29x5.25x4.91x5.07x5.41x5.49x5.42x4.16x4.18x4.83x4.69x4.91x4.60x5.00x4.90x4.64x
Goodwill1.14B1.15B1.6B2.44B2.69B3.98B3.99B3.4B3.43B4.52B5.95B1.99B2.09B2.28B2.21B2.19B1.3B1.31B1.28B1.13B995.38M0000763.27M00000
Intangible Assets924M974M1.21B1.71B1.9B2.32B2.5B2.18B2.42B2.83B2.96B600.7M670.84M795.32M830.64M791.1M78.74M89.09M103.72M76.17M67.65M1B1.25B1.21B1.13B248.89M344.75M349.4M346.1M103.5M256.2M
Long-Term Investments0023M00000-552.8M-718M-848.6M-160.3M-165.55M-238.39M-232.64M-249.82M-72.49M-72.52M-69.05M-60.55M-53.19M0000000000
Other Non-Current Assets321M284M278M48M198M121M95M69M76.8M156.2M64.1M59.1M94.27M220.15M204.9M169.89M138M28.84M67.52M118.55M70.51M59.24M79.86M132.19M98.35M60.86M15.07M15M67.7M246.8M13.3M
Total Assets5.23B5.43B5.75B7.37B7.64B9.24B9.35B8.6B8.69B10.38B11.66B4.4B4.65B5.08B4.97B4.76B3.26B3.09B2.83B2.68B2.18B2.41B2.8B2.45B2.09B1.8B866.62M859.6M895.3M774.4M667.7M
Asset Turnover0.66x0.68x0.66x0.54x0.51x0.46x0.36x0.47x0.46x0.38x0.32x0.61x0.63x0.58x0.59x0.53x0.68x0.70x0.78x0.75x0.83x0.71x0.61x0.64x0.73x0.63x1.03x0.97x0.89x0.93x0.98x
Asset Growth %-45.89%-5.63%-21.94%-3.57%-17.27%-1.19%8.68%-0.97%-16.31%-10.95%164.74%-5.32%-8.42%2.13%4.56%45.96%5.51%9.1%5.79%22.66%-9.39%-13.97%14.42%17.18%16.07%107.49%0.82%-3.99%15.61%15.98%11.71%
Total Current Liabilities1.21B1.34B1.59B1.43B1.17B1.26B1.37B995M1.01B946.6M771M476M653.59M796.4M927.78M724.07M360.09M444.56M359.96M312.41M311.43M741.23M404.61M337.68M365.75M358.52M168.14M176.2M194.4M169.3M143.2M
Accounts Payable259M300M241M305M279M262M302M308M283.9M284.4M223M133.6M132.6M132.79M165.29M149.12M114.48M100.85M104.33M82.32M79.95M82.32M91.58M86.34M66.63M69.9M45.76M44.61M42.7M38.9M33.7M
Days Payables Outstanding53.1559.5147.9459.2556.7350.7665.560.5154.0157.5146.6642.1436.5935.2943.9743.0538.335.136.5531.0133.1135.5139.4339.531.1445.6143.445.3245.6844.4340.49
Short-Term Debt230M360M549M322M118M182M299M2M92.4M30.1M21.1M12.1M112.83M309.86M298.96M276.7M7.75M82.17M25.8M1.24M3M412.21M72.88M21.97M4.55M7.63M794K20.2M16.3M24M26.7M
Deferred Revenue (Current)271M74M95M91M84M68M53M29M29.3M8.9M14.1M2.2M3.48M4.92M5.51M00-110.5M0189.41M181.2M159.85M179.76M172.68M190.78M194.36M00000
Other Current Liabilities718M408M64M458M182M212M166M128M339.1M353.3M260.1M166.9M8.28M197.58M287.6M163.48M146.32M0108.29M0114.86M105.55M122.03M56.69M103.79M86.62M121.58M111.39M135.4M106.4M82.8M
Current Ratio1.53x1.51x1.10x1.38x1.62x1.47x1.31x2.01x1.86x2.12x2.44x2.51x1.85x1.44x1.20x1.40x3.65x2.74x2.64x3.14x2.31x1.39x2.61x2.15x1.48x1.35x1.94x1.79x1.66x1.64x1.79x
Quick Ratio0.98x1.03x0.74x0.95x1.08x1.06x0.96x1.45x1.27x1.46x1.77x1.80x1.25x0.89x0.76x0.90x2.79x2.08x1.79x2.32x1.56x1.11x2.08x1.55x0.89x0.80x1.14x1.02x0.94x0.90x0.92x
Cash Conversion Cycle140.76136.08122.56131.56134.51118.29114.91125.04124.2136.7123.52119.81123.5139.75118.36122.91121.66125.33123.82122.05121.77108.52104.05110.65122.47145.14137.85148.52164.84155.92166.87
Total Non-Current Liabilities2.7B2.75B2.22B2.65B2.66B2.98B3.04B2.51B2.54B2.79B2.76B1.59B1.67B1.7B1.8B2.15B987.95M736.42M882.72M846.76M595.86M424.33M948.97M985.42M884.1M829.68M173.55M212M284.4M177.2M154.6M
Long-Term Debt2.1B2.02B1.59B1.8B1.83B1.91B1.98B1.43B1.56B1.61B1.51B1.14B1.15B1.17B1.22B1.49B604.01M387.15M423.68M482.06M367.16M270.1M779.94M790.2M769.82M723.52M109.5M145.3M217.5M105.5M75.1M
Capital Lease Obligations270M93M91M125M149M149M130M120M00000000000000000000000
Deferred Tax Liabilities374M86M129M0287M391M381M480M552.8M718M848.6M160.3M165.55M238.39M232.64M249.82M72.49M72.52M69.05M60.55M53.19M42.91M58.2M51.24M27.04M32.53M16.82M20.2M18.8M27.6M30M
Other Non-Current Liabilities518M457M415M730M399M528M554M480M975.8M1.18B1.25B446.5M521.59M537.49M573.04M657.16M383.93M349.27M389.99M364.69M175.51M111.31M110.83M143.97M87.24M73.63M47.23M46.5M48.1M44.1M49.5M
Total Liabilities3.91B4.09B3.81B4.08B3.83B4.24B4.42B3.51B3.55B3.74B3.53B2.06B2.33B2.5B2.72B2.87B1.35B1.18B1.24B1.16B907.29M1.17B1.35B1.32B1.25B1.19B341.68M388.2M478.8M346.5M297.8M
Total Debt2.33B2.47B2.27B2.3B2.15B2.29B2.46B1.6B1.66B1.61B1.51B1.14B1.15B1.17B1.22B1.49B604.01M387.15M449.47M483.31M370.16M682.32M852.82M812.17M774.37M731.16M110.29M165.5M233.8M129.5M101.8M
Net Debt2.14B2.14B2B1.97B1.78B1.96B2.02B1.19B1.35B1.29B1.13B856.4M1B1.09B1.14B1.41B63.98M-63.2M245.48M313.92M305.09M247.79M346.45M648.42M748.72M697.45M94.86M158.2M225.1M119.7M96.2M
Debt / Equity1.77x1.84x1.17x0.70x0.56x0.46x0.50x0.31x0.32x0.24x0.19x0.49x0.50x0.45x0.54x0.79x0.32x0.20x0.28x0.32x0.29x0.55x0.59x0.72x0.92x1.20x0.21x0.35x0.56x0.30x0.28x
Debt / EBITDA5.50x4.09x-8.91x-2.40x7.42x2.37x--2.08x2.29x2.01x2.13x2.39x3.86x1.35x0.87x1.03x1.19x1.02x5.53x2.48x2.59x2.58x3.14x0.54x0.87x1.31x0.79x0.69x
Net Debt / EBITDA5.05x3.55x-7.62x-2.05x6.09x1.77x--1.55x1.72x1.74x1.99x2.23x3.66x0.14x-0.14x0.56x0.77x0.84x2.01x1.01x2.07x2.49x3.00x0.46x0.84x1.26x0.73x0.65x
Interest Coverage-5.12x-4.52x-12.57x-1.16x-15.23x9.93x-0.06x12.41x-24.69x-40.93x13.28x6.90x9.51x8.40x6.82x6.72x14.89x21.61x11.93x31.88x30.19x17.20x12.04x10.42x6.65x-16.14x17.60x0.90x16.36x19.92x
Total Equity1.32B1.34B1.94B3.29B3.81B5B4.93B5.09B5.13B6.64B8.13B2.34B2.32B2.58B2.25B1.88B1.91B1.91B1.59B1.52B1.27B1.24B1.44B1.12B837.19M609.96M524.93M471.4M416.5M427.9M369.9M
Equity Growth %-142.05%-31.03%-41.01%-13.59%-23.71%1.26%-3.14%-0.74%-22.71%-18.27%247.35%0.74%-9.92%14.61%19.39%-1.35%0.15%20.11%4.7%19.02%2.6%-14.04%28.69%34.08%37.25%16.2%11.36%13.18%-2.66%15.68%15.85%
Book Value per Share6.606.729.5615.5417.6922.6922.5122.7022.8828.9536.6716.4216.1017.7815.6313.1313.0812.7010.479.808.057.668.816.965.233.863.342.972.592.632.29
Total Shareholders' Equity1.32B1.34B1.94B3.29B3.81B5B4.93B5.09B5.12B6.63B8.11B2.34B2.32B2.54B2.21B1.85B1.84B1.83B1.59B1.52B1.27B1.24B1.44B1.12B835.93M609.52M520.37M468.9M413.8M423.9M365.6M
Common Stock3M3M3M3M3M3M3M3M2.6M2.6M2.6M1.6M1.63M1.63M1.63M1.63M1.63M1.63M1.63M1.63M814K814K814K814K814K814K543K500K000
Retained Earnings-1.57B-1.56B-835M205M456M1.51B1.2B1.4B1.23B2.32B3.95B3.59B3.38B3.1B2.82B2.54B2.32B2.08B1.84B1.58B1.35B1.15B1.13B889.6M730.97M597.41M490.17M402.4M324.7M301.1M237.3M
Treasury Stock0-3.1B-3.14B-2.92B-2.65B-2.54B-2.41B-2.3B-2.15B-1.96B-1.65B-898.4M-841.6M-748.51M-713.74M-727.98M-711.65M-532.02M-479.63M-387.11M-328.18M-138.15M-36.48M-39.84M-52.48M-60.82M-68M-35.92M000
Accumulated OCI-655M-639M-730M-636M-628M-592M-464M-600M-478.7M-291M-705.7M-594M-441.14M-69.06M-144.2M-190.97M24.16M83.54M39.61M145.82M79.91M56.45M164.1M104.54M-275K-80.81M-54.23M-49.7M-80.2M-65M-56.3M
Minority Interest01M1M1M1M1M3M2M11.9M11.6M11.6M1.4M919K42.92M40.74M36.07M70.53M74.85M0296K222K188K600K418K1.26M437K4.56M2.5M2.7M4M4.3M

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Rapidly Deteriorating Equity Base

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Erosion Accelerates Sharply

According to recent quarterly filings, XRAY's total equity has plummeted from $3.3 billion in 2023Q4 to $1.3 billion by 2026Q1, a contraction driven by persistent net losses that signal a weakening financial foundation and significant challenges in stabilizing the company's long-term capital structure.

The consistent decline in retained earnings, which shifted from a positive $205 million to a deficit of $1.6 billion over the observed period, suggests that the company is consuming its capital base to fund restructuring and operational shortfalls. This trajectory warrants caution, as the erosion of equity significantly limits the company's financial flexibility during a period of intense industry competition.

Leverage Ratios Reflect Structural Fragility

As reported in financial statements, XRAY's debt-to-equity ratio has surged from 0.70 in 2023Q4 to 1.77 in 2026Q1, indicating that the company's reliance on debt is increasing precisely as its equity cushion is being depleted by ongoing operational losses and impairment charges.

While the absolute debt level has remained relatively stable near $2.3 billion, the rising leverage ratio is a function of a shrinking denominator rather than aggressive borrowing. This dynamic suggests that the company's ability to service its obligations may become increasingly constrained if the current trend of negative net income persists.

Asset Quality Impairment Risks Loom

Based on reported figures, XRAY's goodwill has declined from $2.4 billion in 2023Q4 to $1.1 billion in 2026Q1, reflecting significant write-downs that suggest previous acquisition strategies have failed to deliver the expected economic value to the core dental technology and equipment business.

The reduction in goodwill, coupled with a stagnant PPE base, indicates that the company is actively clearing impaired assets from its balance sheet. Investors should monitor whether further write-downs are necessary, as the current asset mix remains heavily weighted toward intangible value that may not be fully supported by current cash flow generation.

Liquidity Buffer Shows Concerning Volatility

Data from recent balance sheets reveals that XRAY's cash position has fallen to $190 million in 2026Q1 from a peak of $398 million in 2025Q1, highlighting a tightening liquidity buffer that may leave the firm exposed to unexpected shocks in its working capital requirements.

The current ratio of 1.53 provides a superficial sense of security, but the rapid depletion of cash reserves suggests that the company is burning through its liquid assets to sustain operations. This trend indicates that the firm's ability to fund its ongoing restructuring without external financing may be reaching a critical inflection point.

XRAY — Frequently Asked Questions

Quick answers to the most common questions about buying XRAY stock.

What are the total assets of DENTSPLY SIRONA Inc. (XRAY)?

As of 2025, DENTSPLY SIRONA Inc. (XRAY) had total assets of $5.43B including $2.02B in current assets.

How much debt does DENTSPLY SIRONA Inc. (XRAY) have?

DENTSPLY SIRONA Inc. (XRAY) carries total debt of $2.47B, offset by $326.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of DENTSPLY SIRONA Inc.?

DENTSPLY SIRONA Inc. (XRAY) has total shareholders' equity (book value) of $1.34B ($6.72 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is DENTSPLY SIRONA Inc.'s current ratio and liquidity?

DENTSPLY SIRONA Inc. (XRAY) reported a current ratio of 1.51x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.